The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Francesco Recchia

Civilian Hospital

Oncology Department

Avezzano

Italy

[email]@libero.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Civilian Hospital, Oncology Department, Avezzano, Italy. 2007 - 2011
  • Via Del Castagneto n. 15, 67056 Luco dei Marsi (AQ), Italy. 2010
  • Ospedale Civile di Avezzano, Unità operativa di Oncologia, Italy. 2010
  • Unità Operativa di Oncologia, Ospedale Civile di Avezzano, Avezzano, Italy. 2003 - 2010
  • ALS-1 Civilian Hospital, Avezzano, Oncology Division, Monterotondo, Roma. 2008

References

  1. Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy. Recchia, F., Candeloro, G., Necozione, S., Desideri, G., Recchia, C.O., Piazze, J., Rea, S. Anticancer Res. (2011) [Pubmed]
  2. Prolonged disease control after myeloablative chemotherapy, autologous transplantation and immunotherapy in high-risk early breast cancer. Recchia, F., Candeloro, G., Necozione, S., Accorsi, P., Recchia, C.O., Tombolini, V., Rea, S. Anticancer Res. (2010) [Pubmed]
  3. Maintenance immunotherapy in recurrent ovarian cancer: long term follow-up of a phase II study. Recchia, F., Di Orio, F., Candeloro, G., Guerriero, G., Piazze, J., Rea, S. Gynecol. Oncol. (2010) [Pubmed]
  4. Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier. Recchia, F., Candeloro, G., Guerriero, G., Piazze, J., Desideri, G., Necozione, S., Rea, S. Anticancer. Drugs (2010) [Pubmed]
  5. Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study. Recchia, F., Sica, G., Candeloro, G., Bisegna, R., Bratta, M., Bonfili, P., Necozione, S., Tombolini, V., Rea, S. Pancreas (2009) [Pubmed]
  6. Immunotherapy in patients with less than complete response to chemotherapy. Recchia, F., Candeloro, G., Necozione, S., Bisegna, R., Bratta, M., Rea, S. Anticancer Res. (2009) [Pubmed]
  7. Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: long-term follow-up of a phase II study. Recchia, F., Sica, G., Candeloro, G., Necozione, S., Bisegna, R., Bratta, M., Rea, S. Oncol. Rep. (2009) [Pubmed]
  8. Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck. Recchia, F., Candeloro, G., Di Staso, M., Necozione, S., Bisegna, R., Bratta, M., Tombolini, V., Rea, S. J. Immunother. (2008) [Pubmed]
  9. Alternating XELFOX and XELFIRI in patients with metastatic colorectal cancer. Recchia, F., Candeloro, G., Necozione, S., Bratta, M., Bisegna, R., Rea, S. Am. J. Clin. Oncol. (2008) [Pubmed]
  10. Maintenance immunotherapy in metastatic breast cancer. Recchia, F., Sica, G., Candeloro, G., Necozione, S., Bisegna, R., Bratta, M., Rea, S. Oncol. Rep. (2008) [Pubmed]
  11. Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma. Recchia, F., Candeloro, G., Necozione, S., Fumagalli, L., Bratta, M., Rea, S. Anticancer. Drugs (2008) [Pubmed]
  12. Chemoimmunotherapy in the treatment of metastatic gastric cancer. Recchia, F., Saggio, G., Candeloro, G., Cesta, A., Amiconi, G., Blasio, A.D., Necozione, S., Rea, S. Anticancer. Drugs (2007) [Pubmed]
  13. Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer. Recchia, F., Saggio, G., Cesta, A., Candeloro, G., Di Blasio, A., Amiconi, G., Lombardo, M., Nuzzo, A., Lalli, A., Alesse, E., Necozione, S., Rea, S. Cancer Immunol. Immunother. (2007) [Pubmed]
  14. Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma. Recchia, F., Saggio, G., Amiconi, G., Di Blasio, A., Cesta, A., Candeloro, G., Necozione, S., Fumagalli, L., Rea, S. J. Immunother. (2007) [Pubmed]
  15. A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer. Recchia, F., Saggio, G., Amiconi, G., Di Blasio, A., Cesta, A., Candeloro, G., Carta, G., Necozione, S., Mantovani, G., Rea, S. Gynecol. Oncol. (2007) [Pubmed]
  16. Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer. Recchia, F., Saggio, G., Nuzzo, A., Biondi, E., Di Blasio, A., Cesta, A., Candeloro, G., Alesse, E., Rea, S. J. Immunother. (2006) [Pubmed]
  17. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Recchia, F., Saggio, G., Amiconi, G., Di Blasio, A., Cesta, A., Candeloro, G., Rea, S. Cancer (2006) [Pubmed]
  18. Cardiac metastases in malignant fibrous histiocytoma. A case report. Recchia, F., Saggio, G., Amiconi, G., Di Blasio, A., Cesta, A., Candeloro, G., Rea, S., Nappi, G. Tumori (2006) [Pubmed]
  19. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Recchia, F., Saggio, G., Cesta, A., Amiconi, G., di Blasio, A., Candeloro, G., Valeriani, M., Tombolini, V., Rea, S. Anticancer Res. (2006) [Pubmed]
  20. Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status. Recchia, F., Saggio, G., Cesta, A., Candeloro, G., Rea, S. Anticancer Res. (2005) [Pubmed]
  21. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. Recchia, F., Saggio, G., Cesta, A., Alesse, E., Gallo, R., Necozione, S., Rea, S. Anticancer Res. (2005) [Pubmed]
  22. Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer. Recchia, F., Saggio, G., Cesta, A., Candeloro, G., Nuzzo, A., Lombardo, M., Carta, G., Rea, S. Int. J. Oncol. (2005) [Pubmed]
  23. Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer. Recchia, F., Rea, S., Nuzzo, A., Lalli, A., Di Lullo, L., De Filippis, S., Saggio, G., Biondi, E., Massa, E., Mantovani, G. Anticancer Res. (2004) [Pubmed]
  24. Intermittent chemotherapy may be as effective as indefinite palliative chemotherapy in advanced colorectal cancer. Recchia, F. Cancer Treat. Rev. (2003) [Pubmed]
 
WikiGenes - Universities